According to a new report Asia Pacific Hybrid Imaging Market, published by KBV Research, the Asia Pacific Hybrid Imaging Market would witness market growth of 5.83% CAGR during the forecast period (2019-2025).
The China market dominated the Asia Pacific Diagnostic Imaging Centers Market by Country in 2018, growing at a CAGR of 3.8 % during the forecast period. The Japan market would witness a CAGR of 6.9% during (2019 - 2025). Additionally, The India market would prosper at a CAGR of 7% during (2019 - 2025).
The Oncology market dominated the South Korea Hybrid Imaging Market by Application in 2018, growing at a CAGR of 5.5 % during the forecast period. The Cardiology market is estimated to grow at a CAGR of 7.2% during (2019 - 2025). The Ophthalmology market is exhibiting a CAGR of 5.6% during (2019 - 2025).
The PET/CT systems market dominated the Malaysia Hybrid Imaging Market by Type in 2018, thereby, achieving a market value of $26.9 million by 2025. The SPET/CT systems market is anticipated to witness a CAGR of 6.8% during (2019 - 2025). The PET/MR systems market is poised to grow at a CAGR of 8% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/asia-pacific-hybrid-imaging-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC, Cubersa, Inc., Amber Diagnostics, Inc.
By Application
By Type
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
